zPREDICTA

Drug candidates often fail in clinical trials because preclinical models do not accurately predict human tissue and tumor responses to therapies.

The company provides patient-derived, organ-specific 3D tissue reconstruction models that replicate human microenvironments to predict drug efficacy and clinical outcomes.

Pharmaceutical and biotechnology companies and translational research labs running preclinical drug screening and efficacy studies.